Uterine Cervical Dysplasia Clinical Trial
Official title:
The SAFE Study: Satisfaction and Adherence to Follow-Up With Colposcopy Exams
This study is intended to improve the patient experience of communication of colposcopy results and follow-up recommendations to patients. Current practice involves results being forwarded from the colposcopy clinic to the family or referring physician who then informs the patient. We are testing an intervention informed by focus groups in which a trained colposcopy nurse (patient liaison) directly contacts patients with their results and follow-up recommendations while providing education and support. We will examine whether this intervention improves patient satisfaction, reduces anxiety, and improves rates of adherence to follow-up and treatment appointments compared to the current practice.
Cervical cancer is the second most commonly diagnosed cancer and third leading cause of cancer death in women worldwide. Pre-cancerous cells can be detected with regular Pap smear screening and diagnosed and treated with colposcopy. This process is limited by patient adherence to the follow-up and treatment recommendations. Currently at Vancouver General Hospital (VGH), the largest colposcopy clinic in the province, results are forwarded from the colposcopy clinic to the family or referring physician who informs patients of results and recommendations. Inefficiencies or errors in this step may cause patient dissatisfaction, missed appointments, increased costs, and compromise patient outcomes. The primary objective of this study is to examine whether having a trained colposcopy nurse directly contact patients with their results and follow-up recommendations while providing education and support will improve patient satisfaction and reduce anxiety, with the secondary aim being to assess the clinical effectiveness of this intervention in improving rates of adherence to follow-up and treatment appointments and potentially long-term clinical outcomes. The first phase of the study involves patient focus groups that will be interviewed about what elements of a patient liaison interaction are most important (separate Ethics submission). This information will inform the development of the patient liaison role and approaches to patient interaction to be utilized in the intervention in the second phase. The second phase will entail a randomized controlled trial comparing patient anxiety, satisfaction and adherence to follow-up between a control group (current practice) versus the intervention group exposed to the patient liaison at the VGH Colposcopy Clinic. For the primary aim, a questionnaire containing items pertaining to patient anxiety and satisfaction with their experience of receiving their colposcopy results will be administered both to the intervention and control groups and the mean scores pertaining to anxiety and satisfaction will be compared using two-tailed t-tests. For the secondary aim, a chart review at 6-12 months following the initial colposcopy visit will examine the rates of compliance with the recommended follow-up or treatment visits and histologic diagnoses, and comparisons will be sought between the intervention and control groups using z-score test. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01505920 -
Lidocaine Spray Compared With Submucosal Injection During LEEP: a Randomized Controlled Trial
|
Phase 3 | |
Completed |
NCT01014026 -
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
|
Phase 3 | |
Completed |
NCT00377845 -
Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear.
|
Phase 0 | |
Completed |
NCT02910388 -
LLETZ Under Direct Colposcopic Vision
|
N/A | |
Completed |
NCT00596258 -
A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)
|
Phase 2 | |
Completed |
NCT03763565 -
Effectiveness of HPV Vaccine in Thai Adult Women
|
||
Completed |
NCT04415840 -
Lugol's Solution in Addition to Acetic Acid During Colposcopy
|
||
Recruiting |
NCT04783805 -
Conservative Management of HSIL in Patients With Future Pregnancy Aspiration
|
||
Completed |
NCT04326049 -
LLETZ With Videocolposcopy Versus LLETZ With Binocular Colposcopy
|
N/A | |
Completed |
NCT02515162 -
Fischer Cone Biopsy Excisor Versus Loop Excision Procedure for Conization
|
N/A | |
Completed |
NCT02486471 -
Hemostatic Procedure After Biopsy of the Cervix
|
N/A | |
Completed |
NCT01405768 -
Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs)
|
Phase 2 | |
Completed |
NCT00264732 -
A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix
|
Phase 2/Phase 3 | |
Completed |
NCT02346227 -
Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix
|
Phase 3 | |
Completed |
NCT02330471 -
Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial
|
Phase 3 | |
Completed |
NCT01035580 -
Trial on Safety and Pharmacokinetics of Intravaginal Curcumin
|
Phase 1 | |
Completed |
NCT01639820 -
Comparison of Pelvic Lymphadenectomy Versus Isolated Sentinel Lymph Node Biopsy Procedure for Early Stages of Cervical Cancers : a Multicenter Study With Evaluation of Medico-economic Impacts
|
N/A | |
Completed |
NCT00285207 -
Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix
|
Phase 2 | |
Recruiting |
NCT05225493 -
HIV Indicator Diseases in Hospital and Primary Care
|
||
Completed |
NCT01034358 -
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
|
Phase 4 |